Satish Nadig to Recombinant Fusion Proteins
This is a "connection" page, showing publications Satish Nadig has written about Recombinant Fusion Proteins.
Connection Strength
0.197
-
In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries. Front Immunol. 2021; 12:630581.
Score: 0.166
-
Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
Score: 0.032